The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Factors associated with the use of adjuvant neratinib in stage I-III HER2-positive breast cancer.

Ericson  Stoen

No Relationships to Disclose

Jodi  Kagihara

Employment - Lance M Kagihara, MD (I)

Peter  Kabos

Research Funding - Angiochem (Inst); AstraZeneca (Inst); Genentech (Inst); Lilly (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)

Christine M.  Fisher

No Relationships to Disclose

Jennifer Robinson  Diamond

Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Immunomedics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); OnKure (Inst); Rexahn Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medimmune